Anonymous
Guest
Anonymous
Guest
Admit it: it is time for Amgen to knock off the small molecule nonsense and focus on large molecule therapeutics. It is our real strength. Unfortunately, our leaders have heard this before and believe they are taking us on a more enlightened path.